Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis
Authors:
- Kyle L. PoulsenKPKyle L. Poulsen
- Christopher D. KiblerCKChristopher D. Kibler
- Emily HuangEHEmily Huang
- Xiaoqin WuXWXiaoqin Wu
- Megan R. McMullenMMMegan R. McMullen
- Lin LengLLLin Leng
- Richard BucalaRBRichard Bucala
- Meritxell Ventura-CotsMVMeritxell Ventura-Cots
- Josepmaria ArgemiJAJosepmaria Argemi
- Ramon BatallerRBRamon Bataller
- Laura E. NagyLNLaura E. Nagy
Open Access
- 8 June 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (11)
Abstract
The chemokine system of ligands and receptors is implicated in the progression of alcohol-associated hepatitis (AH). Finding upstream regulators could lead to novel therapies. This study involved coordinated expression of chemokines in livers of healthy controls (HC) and patients with AH in 2 distinct cohorts of patients with various chronic liver diseases. Studies in cultured hepatocytes and in tissue-specific KO were used for mechanistic insight into a potential upstream regulator of chemokine expression in AH. Selected C-X-C chemokine members of the IL-8 chemokine family and C-C chemokine CCL20 were highly associated with AH compared with HC but not in patients with liver diseases of other etiologies (nonalcoholic fatty liver disease [NAFLD] and hepatitis C virus [HCV]). Our previous studies implicate macrophage migration inhibitory factor (MIF) as a pleiotropic cytokine/chemokine with the potential to coordinately regulate chemokine expression in AH. LPS-stimulated expression of multiple chemokines in cultured hepatocytes was dependent on MIF. Gao-binge ethanol feeding to mice induced a similar coordinated chemokine expression in livers of WT mice; this was prevented in hepatocyte-specific Mif –KO ( Mif ΔHep ) mice. This study demonstrates that patients with AH exhibit a specific, coordinately expressed chemokine signature and that hepatocyte-derived MIF might drive this inflammatory response.Keywords
Funding Information
- National Institutes of Health (K99AA026648, R01AA023722, R01AR049610, U01AA020821, P50AA024333, U01AA026938)
- China Scholarship Council (File:201806280215)
This publication has 45 references indexed in Scilit:
- The vascular biology of macrophage migration inhibitory factor (MIF)Thrombosis and Haemostasis, 2013
- The Role of Chemokines in Acute Liver InjuryFrontiers in Physiology, 2012
- Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74Proceedings of the National Academy of Sciences, 2011
- Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver FibrosisPLOS ONE, 2011
- An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in miceHepatology, 2010
- The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory FactorThe Journal of Immunology, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Hepatic Neutrophil Infiltration in the Pathogenesis of Alcohol-Induced Liver InjuryToxicology Mechanisms and Methods, 2007
- Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneGastroenterology, 1996
- Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survivalJournal of Hepatology, 1996